Edward C. English

Chief Financial Officer, PRAECIS PHARMACEUTICALS INC.

Companies

Xilio Therapeutics, Inc.Principal Accounting Officer Nov 16, 2022 to Jan 4, 2023¹
TesaroVP, Controller & Prin Acct Off Dec 21, 2012 to Sep 6, 2017²
AMAG PharmaceuticalsChief financial officer Jun 28, 2011 to Jun 28, 2011³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Xilio Therapeutics, Inc. XLO6,002 shares⁴$50.0K at $8.33Nov 16, 2022

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXilio Therapeutics, Inc., Principal Accounting Officer
2
SEC EDGARTesaro, VP, Controller & Prin Acct Off
3
SEC EDGARAMAG Pharmaceuticals, Chief financial officer
4
SEC EDGARXilio Therapeutics, Inc. shares after the filing of Nov 16, 2022